Pages that link to "Q43607238"
Jump to navigation
Jump to search
The following pages link to Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development (Q43607238):
Displaying 50 items.
- One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling (Q26740548) (← links)
- Histone acetyltransferases: challenges in targeting bi-substrate enzymes (Q26745642) (← links)
- Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy (Q26746038) (← links)
- Dysregulated metabolism contributes to oncogenesis (Q26784630) (← links)
- Epigenetics meets radiation biology as a new approach in cancer treatment (Q27014984) (← links)
- Epigenetic modulators as therapeutic targets in prostate cancer (Q28071912) (← links)
- GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells (Q28477278) (← links)
- Histone variants: emerging players in cancer biology (Q33630867) (← links)
- Exploiting Epigenetic Alterations in Prostate Cancer (Q33755160) (← links)
- Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation (Q34117812) (← links)
- The interaction between epigenetics, nutrition and the development of cancer (Q35131323) (← links)
- SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination (Q35176138) (← links)
- High expression of Sirt7 served as a predictor of adverse outcome in breast cancer (Q35405826) (← links)
- Histone deacetylase inhibitors: emerging mechanisms of resistance. (Q35592607) (← links)
- Epigenetics in prostate cancer (Q35608952) (← links)
- Role of diet in prostate cancer: the epigenetic link (Q35768176) (← links)
- Elevated H3K18 acetylation in airway epithelial cells of asthmatic subjects (Q35937982) (← links)
- Epigenetic regulation of prostate cancer (Q36001910) (← links)
- Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer (Q36135041) (← links)
- Histone modifications and cancer: biomarkers of prognosis? (Q36206499) (← links)
- The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer (Q36390674) (← links)
- Role of several histone lysine methyltransferases in tumor development (Q36639797) (← links)
- A quantitative atlas of histone modification signatures from human cancer cells (Q37008808) (← links)
- Understanding the language of Lys36 methylation at histone H3. (Q37672319) (← links)
- Epigenetics in Prostate Cancer: Biologic and Clinical Relevance (Q37896315) (← links)
- Nuclear morphometry, nucleomics and prostate cancer progression (Q38002780) (← links)
- Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities (Q38115622) (← links)
- Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer (Q38190496) (← links)
- Prostate cancer epigenetic biomarkers: next-generation technologies. (Q38212471) (← links)
- Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer. (Q38242279) (← links)
- An open and shut case for the role of NSD proteins as oncogenes (Q38437979) (← links)
- P110β Inhibition Reduces Histone H3K4 Di-Methylation in Prostate Cancer (Q38734609) (← links)
- The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer (Q39134084) (← links)
- Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers. (Q39316736) (← links)
- A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease (Q39406777) (← links)
- Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer (Q41811530) (← links)
- A transposon-based analysis of gene mutations related to skin cancer development. (Q42510155) (← links)
- Histone demethylation and steroid receptor function in cancer (Q43917365) (← links)
- Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes (Q47144438) (← links)
- Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer Development (Q47742007) (← links)
- SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization. (Q48368878) (← links)
- Altered primary chromatin structures and their implications in cancer development. (Q52878923) (← links)
- Post-Translational Modifications of H2A Histone Variants and Their Role in Cancer. (Q53827263) (← links)
- An Analysis of a Multiple Biomarker Panel to Better Predict Prostate Cancer Metastasis After Radical Prostatectomy (Q57027477) (← links)
- Advances in the computational and molecular understanding of the prostate cancer cell nucleus (Q57107076) (← links)
- Epigenetic regulation of prostate cancer: the theories and the clinical implications (Q57108071) (← links)
- Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion (Q57274753) (← links)
- Cork Oak Young and Traumatic Periderms Show PCD Typical Chromatin Patterns but Different Chromatin-Modifying Genes Expression (Q58700660) (← links)
- The Swr1 chromatin-remodeling complex prevents genome instability induced by replication fork progression defects (Q58751869) (← links)
- NSD2 is a conserved driver of metastatic prostate cancer progression (Q59792587) (← links)